3rd Quarter - Report

MILLER STRATEGIES, LLC for AMGEN, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

LobbyistCovered position, as disclosed
ASHLEY GUNN New Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.
JEFFREY MILLER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Medicare/Medicaid MMM

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 3517 (119th)

Immigration IMM

Issues related to visas

LobbyistCovered position, as disclosed
ASHLEY GUNN —
JEFFREY MILLER —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.